Rectal Cancer: Dynamic Contrast-Enhanced MRI Correlates With Lymph Node Status and Epidermal Growth Factor Receptor Expression
Rectal Cancer: Dynamic Contrast-Enhanced MRI Correlates With Lymph Node Status and Epidermal Growth Factor Receptor Expression
复制标题
DOI:
10.1002/jmri.24301
复制
发表时间:
2014-06-01
影响因子:
4.4
通讯作者:
Oberholzer, Katja
中科院分区:
文献类型:
--
作者:
Lollert, Andre;Junginger, Theodor;Oberholzer, Katja
PurposeTo evaluate correlations between dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and clinicopathologic data as well as immunostaining of the markers of angiogenesis epidermal growth factor receptor (EGFR) and CXC-motif chemokine receptor 4 (CXCR4) in patients with rectal cancer.Materials and MethodsPresurgical DCE-MRI was performed in 41 patients according to a standardized protocol. Two quantitative parameters (k(21), A) were derived from a pharmacokinetic two-compartment model, and one semiquantitative parameter (TTP) was assessed. Standardized surgery and histopathologic examinations were performed in all patients. Immunostaining for EGFR and CXCR4 was performed and evaluated with a standardized scoring system.ResultsDCE-MRI parameter A correlated significantly with the N category (P = 0.048) and k(21) with the occurrence of synchronous and metachronous distant metastases (P = 0.029). A trend was shown toward a correlation between k(21) and EGFR expression (P = 0.107). A significant correlation was found between DCE-MRI parameter TTP and the expression of EGFR (P = 0.044). DCE-MRI data did not correlate with CXCR4 expression.ConclusionDCE-MRI is a noninvasive method which can characterize microcirculation in rectal cancer and correlates with EGFR expression. Given the relationship between the dynamic parameters and the clinicopathologic data, DCE-MRI data may constitute a prognostic indicator for lymph node and distant metastases in patients with rectal cancer. J. Magn. Reson. Imaging 2014;39:1436-1442. (c) 2013 Wiley Periodicals, Inc.